O
LUNG icon

OrbiMed’s Pulmonx LUNG Stock Holding History

OrbiMed’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-435,000
Closed -$7.25K – 126
2022
Q3 		$7.25K Hold
435,000
– – 0.13% 96
2022
Q2 		$6.4K Hold
435,000
– – 0.12% 105
2022
Q1 		$10.8M Hold
435,000
– – 0.18% 98
2021
Q4 		$13.9M Hold
435,000
– – 0.18% 103
2021
Q3 		$15.7M Buy
435,000
+310,000
+248% +$12.2M 0.17% 108
2021
Q2 		$5.51M Hold
125,000
– – 0.06% 145
2021
Q1 		$5.72M Hold
125,000
– – 0.05% 137
2020
Q4 		$8.63M Buy
+125,000
New +$6.12M 0.08% 124

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return